Breaking News, Financial News

Financial Report: Charles River 1Q

Preclinical Services revenue was $140.0 million (-17%) due primarily to slower market demand.

Charles River 1Q

1Q Revenues: $301.5 million (-11%)

1Q Earnings: $25.4 million (-42%)

Comments: Preclinical Services revenue was $140.0 million (-17%) due primarily to slower market demand. Sales for the Research Models and Services segment were $161.5 million in the quarter (-4%).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters